Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...
AZoLifeSciences on MSN
The Promise and Perils of Reprogramming Immunity
The evolution of immunotherapy, featuring CAR-T cells and senolytics, highlights potential in cancer treatment and challenges ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback